SuperworthYarrow Bioscience shares outstanding YARW
Diluted shares outstanding, averaged over each quarter, from 2017.
- Latest quarter, to Jun 30, 2026
- 858K
- On a year earlier
- +0.4%
- more shares
Yarrow Bioscience had 858K diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is about the same as a year earlier.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2024 | 851.6K | +1220% |
| FY2022 | 64.5K | +8% |
| FY2021 | 59.5K | +27% |
| FY2020 | 46.9K | +599% |
| FY2019 | 6.7K | +4% |
| FY2018 | 6.4K | +350% |
| FY2017 | 1.4K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 858K | +0% | |
| Q1 FY26 | 855.4K | +0% | |
| Q2 FY25 | 855K | +0% | |
| Q1 FY25 | 853.5K | +0% | |
| Q4 FY24 | 851.6K | n/a | |
| Q3 FY24 | 851.7K | +1198% | |
| Q2 FY24 | 851.7K | +1201% | |
| Q1 FY24 | 851.6K | +1208% | |
| Q3 FY23 | 65.6K | +2% | |
| Q2 FY23 | 65.5K | +2% | |
| Q1 FY23 | 65.1K | +6% | |
| Q4 FY22 | 64.5K | +8% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Yarrow Bioscience
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.